Jane Street Group, LLC Assembly Biosciences, Inc. Transaction History

Jane Street Group, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.65 - $1.25 $29,183 - $56,122	44,898 New	44,898 $36,000
Q1 2023 May 15, 2023	SELL	$0.8 - $1.74 $42,124 - $91,621	-52,656 Reduced 68.42%	24,305 $20,000
Q4 2022 Feb 14, 2023	BUY	$1.09 - $20.4 $71,687 - $1.34 Million	65,768 Added 587.58%	76,961 $100,000
Q3 2022 Nov 14, 2022	SELL	$1.7 - $20.52 $32,740 - $395,194	-19,259 Reduced 63.24%	11,193 $18,000
Q2 2022 Aug 16, 2022	BUY	$1.35 - $2.29 $23,577 - $39,994	17,465 Added 134.48%	30,452 $64,000
Q1 2022 May 17, 2022	BUY	$1.46 - $2.45 $18,961 - $31,818	12,987 New	12,987 $27,000
Q3 2021 Nov 16, 2021	SELL	$3.14 - $3.9 $113,382 - $140,825	-36,109 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.8 - $4.56 $86,298 - $103,557	22,710 Added 169.49%	36,109 $140,000
Q1 2021 May 18, 2021	BUY	$4.33 - $6.63 $8,534 - $13,067	1,971 Added 17.25%	13,399 $62,000
Q4 2020 Feb 17, 2021	BUY	$4.87 - $17.29 $1,865 - $6,622	383 Added 3.47%	11,428 $69,000
Q3 2020 Nov 17, 2020	BUY	$15.08 - $27.04 $166,558 - $298,656	11,045 New	11,045 $182,000
Q2 2018 Aug 15, 2018	SELL	$39.21 - $50.29 $162,760 - $208,753	-4,151 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$41.7 - $64.16 $173,096 - $266,328	4,151 New	4,151 $204,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $737M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.